NEUROCRINE BIOSCIENCES INC Accrued Liabilities, Current
NEUROCRINE BIOSCIENCES INC (NBIX) had Accrued Liabilities, Current of $18.40 million as of 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2017-05-09
- 2017-03-31: Accrued Liabilities, Current $18.40M.
- 2016-12-31: Accrued Liabilities, Current $21.10M.
- 2016-09-30: Accrued Liabilities, Current $20.75M.
- 2016-06-30: Accrued Liabilities, Current $21.02M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2017-03-31 | $18.40M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $21.10M 10-Q · filed 2017-05-09 |
| 2016-09-30 | $20.75M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $21.02M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $17.13M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $19.03M 10-K · filed 2017-02-14 |
| 2015-09-30 | $14.51M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $12.39M 10-Q · filed 2015-07-29 |
| 2015-03-31 | $9.94M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $11.51M 10-K · filed 2016-02-11 |
| 2014-09-30 | $9.31M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $7.44M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $6.11M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $7.96M 10-K · filed 2015-02-09 |
| 2013-09-30 | $7.88M 10-Q · filed 2013-10-29 |
| 2013-06-30 | $8.19M 10-Q · filed 2013-07-26 |
| 2013-03-31 | $6.58M 10-Q · filed 2013-05-02 |
| 2012-12-31 | $8.09M 10-K · filed 2014-02-11 |
| 2012-09-30 | $8.13M 10-Q · filed 2012-10-31 |
| 2012-06-30 | $6.94M 10-Q · filed 2012-07-31 |
| 2012-03-31 | $6.97M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $8.45M 10-K · filed 2013-02-08 |
| 2011-09-30 | $7.56M 10-Q · filed 2011-10-31 |
| 2011-06-30 | $7.31M 10-Q · filed 2011-07-29 |
| 2010-12-31 | $8.60M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |